Blood or Marrow? MRD poster presented at ESH AML Conference
Click Here to Download the MRD Poster Rarity Bioscience’s Alexander Kele and Ann-Sofi Johansson attended the biannual ESH AML Conference,
Read about our latest news and business activities
Click Here to Download the MRD Poster Rarity Bioscience’s Alexander Kele and Ann-Sofi Johansson attended the biannual ESH AML Conference,
Download the full presentation Our own CTO, Lei Chen, held an award winning presentation at ESCCA 2023 in Utrecht, “Ultra-sensitive molecular MRD
Read the full abstract here We are thrilled to share that Rarity Bioscience together with Karolinska Institutet and Uppsala University
Rarity offers ultra-sensitive and multiplexed mutation detection on 21 of the most common KRAS hotspot mutations for liquid biopsy research.
We can now proudly announce that Rarity Bioscience have achieved the ISO 13485:2016 certification from BSI! The achievement emphasizes Rarity
Industry case by SciLifeLab: Rarity Bioscience and SciLifeLab are collaborating to advance superRCA, a powerful tool for nucleic acid detection.
New perspective article on Liquid Biopsy using superRCA, from Uppsala University and Karolinska Institute: This perspective article compares existing techniques
Per Matsson, an esteemed biotechnology leader, has been appointed as the new chairman of the Board at Rarity Bioscience. His
CEO Linus Bosaeus, CTO Lei Chen and Dir. BD Alexander Kele attended the ISMRC (International Symposium on Minimal Residual Cancer) Conference in Hamburg,
CEO Linus Bosaeus and co-founder and CTO Dr. Lei Chen attended the AML Conference in Munich, Germany 2023, to engage
Using the superRCA technology, you can essentially detect any known sequence of interest using target specific ligation templates and padlock
Last spring, Rarity was awarded a grant from Swelife and Medtech4Health. The idea is to study superRCA for precision diagnostics
To further accelerate growth, Rarity Bioscience announces today a new strategicinvestment from Belgium based Novalis Biotech. The investment is facilitated
With the aim to improve cancer diagnostics, Rarity Bioscience has raised €2,5 million to expand operations and product development within
During November, Rarity Bioscience offer free analysis of liquid biopsy samples for cancer research. Movember is a month-long event to
Speed of Life is a podcast series focusing on innovations accelerating towards better health, by STUNS Life Science. It’s sponsored
Rarity Bioscience was founded in July 2021 based on an innovation by Dr. Lei Chen and Professor Ulf Landegren. Linus
CEO Linus Bosaeus and co-founder and CTO Dr. Lei Chen attended the European Society for Medical Oncology Congress 2022, to
Follow us
Sitemap
Contact us
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.